Trial PaperDepressive DisordersAnxiety DisordersAlcohol Use Disorder (AUD)Substance Use Disorders (SUD)AyahuascaPsilocybin

Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence

This paper (n=3) presents case studies of experiences with the divine in an ongoing clinical trial at NYU exploring the effects of psilocybin on alcohol dependence.

Authors

  • Michael Bogenschutz
  • Susan Mennenga
  • Samantha Podrebarac

Published

Spirituality in Clinical Practice
individual Study

Abstract

Psychedelic substances have been central to religious and shamanic healing practices of various cultures for generations. More recently, in western medicine, psychedelic substances have demonstrated promise in the treatment of various mental health indications. A growing evidence base supports not only the therapeutic potential of psychedelic-assisted psychotherapy, but also the importance of integrating spiritual aspects of psychedelic experiences into the traditional therapeutic process. Psilocybin, a classic psychedelic, is a serotonergic hallucinogen that can elicit profound spiritual experiences even in the research setting. Our group is currently conducting a randomized controlled trial exploring the therapeutic potential of psilocybin-assisted psychotherapy for alcohol dependence. Over the course of the trial, many individuals have reported experiences that take a variety of forms, including spiritual insights, beatific visions, and communion with the Divine. Here we present three case studies of experiences involving communion with a deceased loved one, with a holy figure, and with the Divine from our clinical trial. These cases have been selected to illustrate the diverse nature of the spiritual experiences observed in this clinical trial, and to also explore elements of spiritual care that may be supportive in the psychotherapeutic process during and after the medication experiences. Should psychedelic medicine continue to show treatment promise in clinical trial stages, there is a strong possibility that these medicines will become an integral part of psychotherapy, which will require integration of direct spiritual experiences and spiritual care into the healing process.

Available with Blossom Pro

Research Summary of 'Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence'

Introduction

Podrebarac and colleagues situate their work within a long history of plant- and fungus-based psychedelic use in indigenous ritual contexts, noting that these practices traditionally integrate spiritual and physical dimensions of healing. Earlier waves of Western psychedelic research in the 1950s and 1960s suggested therapeutic promise—particularly for addictions—though many early studies had methodological limitations. More recent research has renewed interest in psychedelic-assisted psychotherapy, with psilocybin shown to reproducibly occasion profound mystical or spiritual-type experiences and, in some trials, to correlate with sustained improvements in mood, social attitudes, and clinical outcomes such as reductions in anxiety, depression, and addictive behaviours. This paper presents three illustrative case reports drawn from an ongoing double-blind, randomised controlled trial of psilocybin-assisted psychotherapy for alcohol dependence. The authors' stated aim is not to adjudicate the ontological status of participants' spiritual encounters but to describe the range of spiritual phenomena observed (communion with the deceased, encounters with holy figures, and communion with a perceived Divine or universal force) and to consider how therapists might support and integrate such experiences within clinical care. The cases were selected to highlight diversity in spiritual content and to explore elements of spiritual care that may aid therapeutic integration.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (25)

Papers cited by this study that are also in Blossom

292 cited
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)

Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism

Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., Johnson, M. W. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)

The therapeutic potential of psychedelic drugs: past, present, and future

Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)

Show all 25 references
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)

Long-term follow-up of psilocybin-facilitated smoking cessation

Johnson, M. W., Garcia-Romeu, A., Griffiths, R. R. · The American Journal of Drug and Alcohol Abuse (2016)

562 cited
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Krebs, T. S., Johansen, P. Ø. · Journal of Psychopharmacology (2012)

A clinical study of LSD treatment in alcoholism

Ludwig, A., Levine, J., Stark, L. et al. · American Journal of Psychiatry (1969)

158 cited
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin

MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)

350 cited
Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy

Ross, S., Malone, T. C., Mennenga, S. E. et al. · Frontiers in Pharmacology (2018)

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C. J. A., McAndrew, A., Stevens, T. et al. · Current Opinion in Behavioral Sciences (2017)

Hallucinogens

Nichols, D. E. · Pharmacology and Therapeutics (2004)

Lysergide Treatment of Schizophrenic and Nonschizophrenic Alcoholics; A Controlled Evaluation

Tomsovic, M., Edwards, R. V. · Journal of Studies on Alcohol and Drugs (1970)

55 cited

Cited By (2)

Papers in Blossom that reference this study

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Spiritual experiences in psychedelic-assisted... — Research Summary & Context | Blossom